At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
HCC Warrior Met Coal LLC
Pre-Mkt 11-02 08:25:57 EST
85.97
+0.35
+0.41%
盘前86.90
+0.93+1.08%
08:23 EST
High86.09Low84.68Vol547.05K
Open85.70D1 Closing85.62Amplitude1.65%
Mkt Cap4.52BTradable Cap4.45BTotal Shares52.57M
T/O46.86MT/O Rate1.06%Tradable Shares51.78M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Earning Preview: Warrior Met Coal LLC this quarter’s revenue is expected to increase by 64.20%, and institutional views are Neutral
Earnings Agent  ·  10-28
Earning Preview: Warrior Met Coal LLC this quarter’s revenue is expected to increase by 64.20%, and institutional views are Neutral
Can-Fite Announces Eurasian Patent Allowance Supporting Piclidenoson Development and Commercialization in Lowe Syndrome
GlobeNewswire  ·  20:00
Can-Fite Announces Eurasian Patent Allowance Supporting Piclidenoson Development and Commercialization in Lowe Syndrome
Warrior Met Coal Declares Special Cash Dividend
THOMSON REUTERS  ·  10-29
Warrior Met Coal Declares Special Cash Dividend
Junshi Biosciences Announces the Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS207 in Combination with JS007 for the First-Line Treatment of Advanced Hepatocellular Carcinoma
GlobeNewswire  ·  10-29
Junshi Biosciences Announces the Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS207 in Combination with JS007 for the First-Line Treatment of Advanced Hepatocellular Carcinoma
Junshi Biosciences Announces Final Analysis Results of the Phase 3 NEOTORCH Study at ESMO Congress 2026
GlobeNewswire  ·  10-28
Junshi Biosciences Announces Final Analysis Results of the Phase 3 NEOTORCH Study at ESMO Congress 2026
Warrior Met Coal Keeps Quarterly Dividend at $0.08 a Share, Payable Nov. 13 to Holders of Record Nov. 6
MT Newswires Live  ·  10-28
Warrior Met Coal Keeps Quarterly Dividend at $0.08 a Share, Payable Nov. 13 to Holders of Record Nov. 6
Press Release: Warrior Announces Regular Quarterly Cash Dividend
Dow Jones  ·  10-28
Press Release: Warrior Announces Regular Quarterly Cash Dividend
Warrior Met Coal is Maintained at Buy by B. Riley Securities
Dow Jones  ·  10-26
Warrior Met Coal is Maintained at Buy by B. Riley Securities
B. Riley Trims Price Target on Warrior Met Coal to $122 From $123, Keeps Buy Rating
MT Newswires Live  ·  10-26
B. Riley Trims Price Target on Warrior Met Coal to $122 From $123, Keeps Buy Rating
Can-Fite Presents Final Positive Data from Phase IIa Pancreatic Cancer Study of Namodenoson at ESMO 2026
GlobeNewswire  ·  10-26
Can-Fite Presents Final Positive Data from Phase IIa Pancreatic Cancer Study of Namodenoson at ESMO 2026
Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Stage in Phase II First-Line Gastric Cancer Study
GlobeNewswire  ·  10-20
Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Stage in Phase II First-Line Gastric Cancer Study
Leads Biolabs' Opamtistomig and LBL-034 Featured in Six Abstracts at 2026 ESMO Congress
GlobeNewswire  ·  10-19
Leads Biolabs' Opamtistomig and LBL-034 Featured in Six Abstracts at 2026 ESMO Congress
Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Enrolls First Patient in Phase Ib/II Combination Trial in Metastatic Colorectal Cancer
GlobeNewswire  ·  10-16
Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Enrolls First Patient in Phase Ib/II Combination Trial in Metastatic Colorectal Cancer
How Investors Are Reacting To Warrior Met Coal (HCC) Blue Creek Ramp Up
Simply Wall St.  ·  10-15
How Investors Are Reacting To Warrior Met Coal (HCC) Blue Creek Ramp Up
Press Release: Warrior Sets Date for Third Quarter 2026 Earnings Announcement and Investor Conference Call
Dow Jones  ·  10-15
Press Release: Warrior Sets Date for Third Quarter 2026 Earnings Announcement and Investor Conference Call
Warrior Met Coal Publishes Update to Financial Calendar
Reuters  ·  10-15
Warrior Met Coal Publishes Update to Financial Calendar
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Granted FDA Fast Track Designation for First-Line Advanced or Metastatic Biliary Tract Cancer
GlobeNewswire  ·  10-12
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Granted FDA Fast Track Designation for First-Line Advanced or Metastatic Biliary Tract Cancer
RBC Capital Keeps Their Hold Rating on Warrior Met Coal (HCC)
TIPRANKS  ·  10-09
RBC Capital Keeps Their Hold Rating on Warrior Met Coal (HCC)
Warrior Met Coal is Maintained at Buy by UBS
Dow Jones  ·  10-09
Warrior Met Coal is Maintained at Buy by UBS
UBS Adjusts Price Target on Warrior Met Coal to $102 From $98, Maintains Buy Rating
MT Newswires Live  ·  10-08
UBS Adjusts Price Target on Warrior Met Coal to $102 From $98, Maintains Buy Rating

Introduction

Company Name.
Warrior Met Coal LLC
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Warrior Met Coal, Inc. produces and exports non-thermal metallurgical coal for the steel industry. It operates two underground mines located in Alabama. The company sells its metallurgical coal to a customer base of blast furnace steel producers located primarily in Europe, South America, and Asia. It also sells natural gas, which is extracted as a byproduct from coal production. Warrior Met Coal, Inc. was incorporated in 2015 and is headquartered in Brookwood, Alabama.
Issue price:
--